ICD1850K ;ALB/MJB - YEARLY DRG UPDATE;8/9/2010
 ;;18.0;DRG Grouper;**50**;Oct 13, 2000;Build 8
 ;
 ; Updates for DRGS 810-999
 Q
 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS^
 ;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^0.923^3^3.7
 ;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.2544^3.8^5.2
 ;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^0.7957^2.8^3.6
 ;;813^16^MED^COAGULATION DISORDERS^1.4372^3.6^5
 ;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.6431^5^6.9
 ;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^1.0024^3.6^4.6
 ;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^0.6818^2.6^3.2
 ;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^5.7112^13.1^17.2
 ;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.3998^5.3^7.4
 ;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.2253^2.3^3.1
 ;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W MCC^4.564^12.2^15.9
 ;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W CC^2.3055^6.6^8.7
 ;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W/O CC/MCC^1.2418^2.8^4
 ;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^4.8666^11.2^14.7
 ;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.1459^5.3^6.9
 ;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.3861^3.1^3.8
 ;;829^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W CC/MCC^2.7093^6.3^9.4
 ;;830^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W/O CC/MCC^1.0976^2.4^3.2
 ;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^4.9277^10.1^16.2
 ;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.4284^5.7^9.2
 ;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.1386^3^4.5
 ;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^6.6599^17.8^23.5
 ;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^3.1428^8.1^12.2
 ;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.2823^4.6^5.7
 ;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^2.9317^7.8^10.6
 ;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6376^5.1^6.8
 ;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.0389^3.2^4.2
 ;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.8363^6^8
 ;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.194^4.3^5.6
 ;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^0.8029^2.9^3.7
 ;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.1961^5.4^8
 ;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^0.986^2.8^3.4
 ;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^0.8078^2.4^3
 ;;849^17^MED^RADIOTHERAPY^1.2627^4.4^6.1
 ;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.5237^12^15.6
 ;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.7883^8.2^10
 ;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.3797^3.9^5.3
 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^5.1296^11.2^15
 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^2.0975^6.2^7.9
 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.305^4.1^5.1
 ;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^1.9511^5.8^7.7
 ;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^0.979^4^4.9
 ;;864^18^MED^FEVER^0.8276^3^3.8
 ;;865^18^MED^VIRAL ILLNESS W MCC^1.5651^4.5^6.5
 ;;866^18^MED^VIRAL ILLNESS W/O MCC^0.7462^2.8^3.5
 ;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.4708^6.7^9.2
 ;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.1614^4.3^5.4
 ;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^0.7207^3^3.6
 ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV 96+ HOURS^5.8305^12.8^15.1
 ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W MCC^1.9074^5.4^7.2
 ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W/O MCC^1.1545^4.5^5.4
 ;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^2.8143^8.1^12.7
 ;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^0.6161^2.3^3
 ;;881^19^MED^DEPRESSIVE NEUROSES^0.6178^3.1^4.2
 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.6276^3.1^4.3
 ;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.0694^4.9^7.7
 ;;884^19^MED^ORGANIC DISTURBANCES & MENTAL RETARDATION^0.9308^4^5.3
 ;;885^19^MED^PSYCHOSES^0.9041^5.4^7.4
 ;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^0.7903^3.8^5.9
 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^0.7888^2.9^4.1
 ;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.4074^2.1^3
 ;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^1.0275^8.5^10.9
 ;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.4565^4.7^6.5
 ;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^0.6513^3.2^4
 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^3.9042^9.1^14
 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.7922^5.4^7.5
 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^1.0624^3.3^4.4
 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^2.9335^7.2^10.9
 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.1714^3.4^4.5
 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.0356^2.1^3.1
 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^3.8268^7.8^11.1
 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^1.9251^4.7^6.3
 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.1554^2.6^3.4
 ;;913^21^MED^TRAUMATIC INJURY W MCC^1.3444^4^5.6
 ;;914^21^MED^TRAUMATIC INJURY W/O MCC^0.6994^2.6^3.2
 ;;915^21^MED^ALLERGIC REACTIONS W MCC^1.4252^3.6^5.1
 ;;916^21^MED^ALLERGIC REACTIONS W/O MCC^0.4867^1.7^2.1
 ;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4868^3.7^5.1
 ;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^0.6269^2.1^2.7
 ;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.5903^4.4^6.2
 ;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^0.9785^3.2^4.3
 ;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^0.6216^2.2^2.8
 ;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.3478^3.8^5.4
 ;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^0.6808^2.3^3.2
 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W SKIN GRAFT^12.6651^21.8^28.5
 ;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^4.7724^10.8^14.8
 ;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.0557^5.2^7.7
 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W/O SKIN GRAFT^2.1979^2.3^5.1
 ;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ^1.3556^4.1^5.8
 ;;935^22^MED^NON-EXTENSIVE BURNS^1.2919^3.5^5.2
 ;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^2.8702^6.9^10
 ;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^1.6797^3.6^5.4
 ;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.1457^2^2.6
 ;;945^23^MED^REHABILITATION W CC/MCC^1.2795^8.2^10.1
 ;;946^23^MED^REHABILITATION W/O CC/MCC^1.1273^6.6^7.5
 ;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.0952^3.7^4.9
 ;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^0.6865^2.7^3.4
 ;;949^23^MED^AFTERCARE W CC/MCC^1.0006^2.6^4.4
 ;;950^23^MED^AFTERCARE W/O CC/MCC^0.504^2.2^2.8
 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.6593^2.2^4
 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^5.5336^8.9^12.6
 ;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.3704^7^8.5
 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^6.2519^10.1^14.2
 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^3.7692^7.5^9.6
 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.3208^4.7^5.9
 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.8123^6^8.7
 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.4901^4.5^5.6
 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^0.9386^3.1^3.8
 ;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.5073^12^17.1
 ;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.6755^6.3^8.6
 ;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.5849^6.8^9.6
 ;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.364^5.1^6.6
 ;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^0.8975^3.5^4.4
 ;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.0486^3.7^4.9
 ;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^5.0634^11^14.1
 ;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.9402^6.8^8.7
 ;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.7767^3.1^4.3
 ;;984^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.3242^10.5^13.3
 ;;985^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.1508^6.8^9
 ;;986^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.114^2.7^4
 ;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.4495^9.3^12.1
 ;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.8739^5.6^7.4
 ;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0589^2.5^3.5
 ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0^0^0
 ;;999^99^**^UNGROUPABLE^0^0^0
 ;;EXIT
 Q
